No Picture
News

T2 Biosystems T2SARS-CoV-2™ Panel Detects Omicron Variant

LEXINGTON, Mass., Dec. 01, 2021 (GLOBE NEWSWIRE) — T2 Biosystems, Inc. (NASDAQ:TTOO),  a leader in the rapid detection of sepsis-causing pathogens, today announced that its T2SARS-CoV-2™ Panel detects the Omicron COVID-19 variant (B.1.1.529). Click here to view original post… […]

No Picture
News

T2 Biosystems Announces Continued International Expansion into Taiwan with Exclusive Distribution Agreement

LEXINGTON, Mass., Nov. 19, 2021 (GLOBE NEWSWIRE) — T2 Biosystems, Inc. (NASDAQ:TTOO), a leader in the rapid detection of sepsis-causing pathogens, today announced the execution of a territory exclusive distribution agreement in Taiwan.   Click here to view original post… […]

No Picture
News

T2 Biosystems to Report Third Quarter 2021 Financial Results on November 4, 2021

LEXINGTON, Mass., Oct. 22, 2021 (GLOBE NEWSWIRE) — T2 Biosystems, Inc. (NASDAQ:TTOO), a leader in the rapid detection of sepsis-causing pathogens, announced today that it will report financial results for the third quarter of 2021 after market close on Thursday, November 4, 2021. Company management will host a corresponding conference call beginning… Click here to view original post… […]

No Picture
News

T2 Biosystems T2SARS-CoV-2™ Panel Proves Capable of Detecting the Mu B.1.621 and Iota B.1.526 Variants of the SARS-CoV-2 Virus

LEXINGTON, Mass., Sept. 09, 2021 (GLOBE NEWSWIRE) — T2 Biosystems, Inc. (NASDAQ:TTOO), a leader in the rapid detection of sepsis-causing pathogens, today announced that its T2SARS-CoV-2™ Panel—a molecular diagnostic test that detects SARS-CoV-2, the virus responsible for COVID-19 infections—is capable of detecting the Mu (B.1.621) and Iota (B.1.526) variants of the… Click here to view original post… […]

No Picture
News

T2 Biosystems Announces Plans to Consolidate and Expand Facilities in Massachusetts

LEXINGTON, Mass., Sept. 08, 2021 (GLOBE NEWSWIRE) — T2 Biosystems, Inc. (NASDAQ:TTOO), a leader in the rapid detection of sepsis-causing pathogens, announced today plans to consolidate its existing facilities and expand into a newly leased facility in Billerica, Massachusetts. The Company will consolidate its existing operations in Lexington, MA and… Click here to view original post… […]

No Picture
News

T2 Biosystems to Participate in the Canaccord Genuity 41st Annual Growth Conference

LEXINGTON, Mass., Aug. 04, 2021 (GLOBE NEWSWIRE) — T2 Biosystems, Inc. (NASDAQ:TTOO), a leader in the rapid detection of sepsis-causing pathogens, today announced plans to participate in the upcoming Canaccord Genuity 41st Annual Growth Conference. Click here to view original post… […]

No Picture
News

T2 Biosystems to Report Second Quarter 2021 Financial Results on August 5, 2021

LEXINGTON, Mass., July 22, 2021 (GLOBE NEWSWIRE) — T2 Biosystems, Inc. (NASDAQ:TTOO), a leader in the rapid detection of sepsis-causing pathogens, announced today that it will report financial results for the second quarter of 2021 after market close on Thursday, August 5, 2021. Company management will host a corresponding conference call… Click here to view original post… […]

No Picture
News

T2 Biosystems Reports Granting of Inducement Award

LEXINGTON, Mass., July 19, 2021 (GLOBE NEWSWIRE) — T2 Biosystems, Inc. (NASDAQ:TTOO) a leader in the rapid detection of sepsis-causing pathogens, announced today that it issued inducement awards to eleven new employees. Click here to view original post… […]